Both in Pharmaceuticals
Harmony Biosciences Holdings vs First Tracks Biotherapeutics
Over the past year HRMY returned −17.1% and TRAX returned +34.6%; their daily moves had a correlation of 0.07.
HRMY −17.1% TRAX +34.6%Growth of $1, one year, split-adjusted
| Metric | HRMY | TRAX |
|---|---|---|
| Price | $34.42 | $49.04 |
| Market cap | $2.00B | $2.06B |
| Today | −7.04% | +5.83% |
| 1 month | −12.6% | +56.2% |
| 6 months | +5.0% | — |
| Year to date | −8.0% | — |
| 1 year | +17.3% | — |
| Revenue growth (YoY) | +30.3% | — |
| Gross margin | 75.8% | — |
| Net margin | 28.9% | — |
| P/E (TTM) | 11.1× | — |
| Price / sales | 2.1× | — |
| Net cash | $513.8M | $168.0M |
| Dividend yield | — | — |
| Volatility (60d) | 35.9% | — |
| Short % of float | 11.8% | 21.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).